Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(18)30566-7
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Primary Debulking Surgery Versus Primary Neoadjuvant Chemotherapy for High Grade Advanced Stage Ovarian Cancer: Comparison of Survivals

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

A Meta-Analysis: Neoadjuvant Chemotherapy Versus Primary Surgery in Ovarian Carcinoma FIGO stageIII and IV

World Journal of Surgical Oncology
SurgeryOncology
2013English

Pathological Chemotherapy Response Score Is Prognostic in Tubo-Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis of Individual Patient Data

Gynecologic Oncology
GynecologyOncologyObstetrics
2019English

Interval Debulking Surgery for Advanced Epithelial Ovarian Cancer

Cochrane Database of Systematic Reviews
2016English

Interval Debulking Surgery for Advanced Epithelial Ovarian Cancer

2010English

Sharing Individual Patient Data From Clinical Trials

New England Journal of Medicine
Medicine
2015English

Neoadjuvant Chemotherapy for Patients With Advanced Epithelial Ovarian Cancer: A Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

A Pooled Analysis of Individual Patient Data From National Clinical Trials Network Clinical Trials of Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in Elderly Patients Versus Younger Patients

Cancer
Cancer ResearchOncology
2018English

Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Latest Results and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy